Article Details

IN BRIEF: Silence Therapeutics revenue up, new targets with AstraZeneca

Retrieved on: 2021-08-12 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

IN BRIEF: Silence Therapeutics revenue up, new targets with AstraZeneca. View article details on hiswai:

Excerpt

Interim revenue from collaborations is GBP5.8 million, up from GBP1.1 million last year, driven by collaboration with AstraZeneca PLC and ...

Article found on: www.morningstar.co.uk

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up